Skip to main content
22 October 2024
Last updated:
Sunday 20 October 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Europe's capital markets continue to struggle
Read more
Europe's pharma groups change product mix
Read more
Novartis sets out its vision for pharma R&D
Read more
Battle looms over immunotherapy combination
Read more
Innate Pharma aims to regain leadership in IO
Read more
Takeovers refocus Sanofi on rare diseases
Read more
The case for optimism for Europe's biotech sector
Read more
Priorities of the new Novartis CEO
Read more
Ipsen aspires to role as speciality oncology player
Read more
Drugs for orphan diseases are no longer rare
Read more
Pagination
Current page
1
Page
2
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form